Lilly to buy cancer drug developer AurKa Pharma

May 15, 2018 , CNBC Health
Eli Lilly will buy AurKa Pharma in a deal potentially worth up to $575 million.

Read the full story...

Trending healthcare news keywords at this moment

teen risk heart diabetes fda cancer patients longer disease tip shutdown flu sleep women ceo hospitals drug prices lung therapy life global adds medicaid birth control research healthcare medicare researchers launches pharma study food found state hospital care opioid save tied growth cvs digital doctors pain generic report americans marketing kids shows treatment change data walmart type